4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-006823
Global President TAVR & Surg sold 8,660 shares at an average $90.15 ($780,681)
- Global President TAVR & Surg acquired 8,660 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Wood Larry L · Global President TAVR & Surg
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,660 | $45.28 | $392,096 | 222,453.71 | D |
| 2023-06-14 | Sale : show line 2 in the form 10b5-1 | −2,850 | $90.71 | $258,528 | 219,603.71 | D |
| 2023-06-14 | Sale : show line 3 in the form 10b5-1 | −5,810 | $89.87 | $522,152 | 213,793.71 | D |
| Open-market sales · 8,660 sh · avg $90.15 · $780,681 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-06-14 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −8,660 | $45.28 | 2025-05-16 | 8,660 | 49,719 | D |
Loading xslF345X04/doc4.xml…